Pain Evaluation and Treatment in Clinical Settings

Launched by RUBENS DA SILVA · Jan 5, 2022

Keywords

ClinConnect Summary

The "Pain Evaluation and Treatment in Clinical Settings" trial is focused on understanding and improving how we assess and treat chronic pain, especially for people with musculoskeletal disorders. This research is a collaboration between a hospital in Brazil and two universities in Canada, aiming to create a comprehensive approach to pain management. By using advanced technology to measure how the central nervous system responds to pain, the study hopes to gather important data that can help healthcare providers offer better care and improve the quality of life for patients experiencing pain.

To be eligible for this trial, participants need to be adults between the ages of 20 and 85 who have a diagnosis of a musculoskeletal disorder. They should be able to perform some physical tasks and have a certain level of cognitive ability. The study will not include individuals with severe conditions like cancer or major psychiatric disorders. Those who participate can expect to undergo various tests and evaluations to help researchers learn more about how pain affects them and to develop better treatments. Overall, this trial is an exciting opportunity for patients to contribute to research that aims to make a significant difference in pain care in Brazil and beyond.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults males and females
• • Age ≥ 20 years and older (≤ 85)
• • Body mass index (BMI) between 18 and 35 kg/m2
• • From local the community, or be in the waiting list, or be admitted in ISCAL - Irmandande Santa Casa de Londrina (Londrina Santa Casa Hospital)
• • Present, at least, 1 diagnosis of musculoskeletal disorder (medical diagnosis declared by the doctors of the clinical team of the hospital)
• • Be able to present to the room and perform the tests and functional tasks, without and with minimal assistance
• • Present a cognitive state greater than 20 in Mini-Mental State Examination.
• Exclusion Criteria:
• • Cancer
• • Red flags (infection, tumor, etc.)
• • Severe psychiatric disorders
• • Palliative care
• • Congenital spinal deformity (spondylolysis, intervertebral fusions, 4 lumbar vertebrae)
• • Fairly severe systemic syndromes or diseases that may preclude testing
• • Stroke - very acute phase (1 week) and this is until medial hemodynamic stability
• • Any drugs or condition that could affect EEG or rMT measurements